title: Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.
abstract: Foreign body-type multinucleated giant cells (FBGC), formed by macrophage fusion, are a prominent cell type on implanted biomaterials, although the roles they play at these and other sites of chronic inflammation are not understood. Why lymphocytes are present in this scenario and the effects of fusing macrophages/FBGC on subsequent lymphocyte responses are also unclear. To address the physiological significance of FBGC in this regard, we employed our in vitro system of interleukin (IL)-4-induced human monocyte-derived macrophage fusion/FBGC formation. Initially, we pursued the identities of lymphocyte co-stimulatory molecules on fusing macrophages/FBGC. In addition, we further compared the FBGC phenotype to that currently associated with osteoclasts and dendritic cells using recognized markers. Immunoblotting of cell lysates and immunochemistry of macrophages/FBGC in situ, revealed that IL-4-induced macrophages/FBGC strongly express HLA-DR, CD98, B7-2 (CD86), and B7-H1 (PD-L1), but not B7-1 (CD80) or B7-H2 (B7RP-1). Furthermore, molecules currently recognized to be expressed on osteoclasts (calcitonin receptor, tartrate-resistant acid phosphatase, RANK) or dendritic cells (CD1a, CD40, CD83, CD95/fas) are undetectable. In contrast, fusing macrophages/FBGC strongly express the macrophage markers αX integrin (CD11c), CD68, and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), whereas CD14 is completely down-modulated with IL-4-induced macrophage fusion. These novel data demonstrate that IL-4-induction of macrophage multinucleation/FBGC formation features the acquisition of a CD14-negative phenotypic profile which is distinguishable from that of dendritic cells and osteoclasts, yet potentially exhibits multiple capacities for lymphocyte interactions with resultant lymphocyte down-modulation.
authors.affiliation: Department of Pathology, Case Western Reserve University, Wolstein Research Building, Room 5104, 2103 Cornell Road, Cleveland, OH 44106, USA. akm2@case.edu
authors.forename: Amy K
authors.initials: AK
authors.lastname: McNally
authors.forename: James M
authors.initials: JM
authors.lastname: Anderson
mesh_terms: D000135:Acid Phosphatase / Q000096:biosynthesis; D015703:Antigens, CD / Q000096:biosynthesis; D060887:B7 Antigens / Q000096:biosynthesis; D015815:Cell Adhesion Molecules / Q000096:biosynthesis; D002459:Cell Fusion; D003713:Dendritic Cells / Q000166:cytology / Q000378:metabolism; D015743:Giant Cells, Foreign-Body / Q000166:cytology / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping; D015847:Interleukin-4; D007527:Isoenzymes / Q000096:biosynthesis; D037181:Lectins, C-Type / Q000096:biosynthesis; D008262:Macrophage Activation; D008264:Macrophages / Q000166:cytology; D009000:Monocytes / Q000166:cytology; D010010:Osteoclasts / Q000166:cytology / Q000378:metabolism; D018003:Receptors, Calcitonin / Q000096:biosynthesis; D011956:Receptors, Cell Surface / Q000096:biosynthesis; D000071681:Tartrate-Resistant Acid Phosphatase; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin
chemical_list: D000135:Acid Phosphatase; D015703:Antigens, CD; D060887:B7 Antigens; D015815:Cell Adhesion Molecules; D015847:Interleukin-4; D007527:Isoenzymes; D037181:Lectins, C-Type; D018003:Receptors, Calcitonin; D011956:Receptors, Cell Surface; D000071681:Tartrate-Resistant Acid Phosphatase; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin